drugset / Trial / NCT04267679

Cannabidiol for Anxiety

NCT04267679 ↗

NaSingle-groupOpen-labelTreatment

Summary

This pilot trial seeks to investigate the effect of 25 mg full-spectrum CBD soft gel capsules (up to a total dosage of 100mg per day) on individuals with diagnosed anxiety. All participants will take CBD soft gel capsules for 12 weeks, and will be assessed at 6 weeks and 12 weeks post-enrollment using measures of anxiety, sleep and perception of change.

Timeline

Start
2020-03-01
Primary completion
2020-12-01
Completion
2020-12-01

Outcome

Outcome not reported

Stopped: “Stopped due to COVID-19 pandemic.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 25 mg —

Indications